Adherence to metformin in people with type 2 diabetes mellitus: results from the first New Zealand-wide study
Tuesday, 19 November 2019
In a national study, researchers from the Pharmacoepidemiology Research Network at the University of Otago have found sub-optimal levels of adherence to metformin, the recommended first-line drug used to treat type 2 diabetes.
